A detailed history of Black Rock Inc. transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,482,400 shares of MTNB stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,482,400
Previous 2,482,400 -0.0%
Holding current value
$1.44 Million
Previous $670,000 40.75%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.19 - $0.3 $3,536 - $5,583
-18,611 Reduced 0.74%
2,482,400 $670,000
Q4 2023

Feb 13, 2024

SELL
$0.12 - $0.64 $29 - $155
-243 Reduced 0.01%
2,501,011 $550,000
Q3 2023

Nov 13, 2023

SELL
$0.12 - $0.41 $773 - $2,642
-6,445 Reduced 0.26%
2,501,254 $325,000
Q2 2023

Aug 11, 2023

BUY
$0.35 - $0.72 $13,909 - $28,614
39,742 Added 1.61%
2,507,699 $902,000
Q1 2023

May 12, 2023

SELL
$0.39 - $0.6 $96,791 - $148,909
-248,183 Reduced 9.14%
2,467,957 $1.16 Million
Q4 2022

Feb 13, 2023

SELL
$0.46 - $42.69 $718,969 - $66.7 Million
-1,562,978 Reduced 36.53%
2,716,140 $1.36 Million
Q3 2022

Nov 14, 2022

SELL
$0.63 - $33.0 $41,478 - $2.17 Million
-65,839 Reduced 1.52%
4,279,118 $2.72 Million
Q2 2022

Aug 12, 2022

BUY
$0.63 - $0.96 $12,539 - $19,107
19,904 Added 0.46%
4,344,957 $3.43 Million
Q1 2022

May 12, 2022

BUY
$0.5 - $1.06 $14,821 - $31,421
29,643 Added 0.69%
4,325,053 $3.48 Million
Q4 2021

Feb 10, 2022

BUY
$0.92 - $1.22 $1.45 Million - $1.92 Million
1,571,635 Added 57.7%
4,295,410 $4.34 Million
Q3 2021

Nov 09, 2021

BUY
$0.67 - $1.51 $14,916 - $33,618
22,264 Added 0.82%
2,723,775 $3.54 Million
Q2 2021

Aug 11, 2021

BUY
$0.75 - $1.1 $2.03 Million - $2.97 Million
2,701,511 New
2,701,511 $2.09 Million

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $126M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.